0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Compounded Topical Drug Market Research Report 2026
Published Date: 2026-01-30
|
Report Code: QYRE-Auto-21R18390
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Compounded Topical Drug Market Research Report 2024
BUY CHAPTERS

Global Compounded Topical Drug Market Research Report 2026

Code: QYRE-Auto-21R18390
Report
2026-01-30
Pages:121
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Compounded Topical Drug Market Size

The global Compounded Topical Drug market was valued at US$ 4978 million in 2025 and is anticipated to reach US$ 7109 million by 2032, at a CAGR of 5.3% from 2026 to 2032.

Compounded Topical Drug Market

Compounded Topical Drug Market

A compounded topical drug refers to a medication specifically prepared by a pharmacist according to a doctor's prescription, tailored to meet the individual needs of a patient. These medications are applied directly to the skin and are custom-mixed to address specific medical conditions such as skin irritations, pain management, or hormone therapy. Compounded topical drugs are not mass-produced but are made on-demand, offering personalized dosages, combinations of active ingredients, and delivery methods based on the patient’s unique requirements.
The North American market for Compounded Topical Drug is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Compounded Topical Drug is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Compounded Topical Drug in Hospitals is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Compounded Topical Drug include Fagron, Fresenius Kabi, PharMEDium Services, Institutional Pharmacy Solutions, Cantrell Drug Company, Lorraine’s Pharmacy, B. Braun Melsungen AG Company, Perrigo Company plc, Nephron Pharmaceuticals Corporation, PCCA (Professional Compounding Centers of America), etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Compounded Topical Drug market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Compounded Topical Drug. The Compounded Topical Drug market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Compounded Topical Drug market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Compounded Topical Drug manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Compounded Topical Drug Market Report

Report Metric Details
Report Name Compounded Topical Drug Market
Accounted market size in 2025 US$ 4978 million
Forecasted market size in 2032 US$ 7109 million
CAGR 5.3%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Gels
  • Ointments
  • Cream
  • Lotions
Segment by Application
  • Hospitals
  • Retail Pharmacy
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Fagron, Fresenius Kabi, PharMEDium Services, Institutional Pharmacy Solutions, Cantrell Drug Company, Lorraine’s Pharmacy, B. Braun Melsungen AG Company, Perrigo Company plc, Nephron Pharmaceuticals Corporation, PCCA (Professional Compounding Centers of America), Medisca, Central Admixture Pharmacy Services (CAPS), Avella Specialty Pharmacy, Triangle Compounding Pharmacy, CareFirst Specialty Pharmacy, Pharmaca Integrative Pharmacy, QuVa Pharma, Custom Scripts Pharmacy, Atlas Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Compounded Topical Drug companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Compounded Topical Drug Market growing?

Ans: The Compounded Topical Drug Market witnessing a CAGR of 5.3% during the forecast period 2026-2032.

What is the Compounded Topical Drug Market size in 2032?

Ans: The Compounded Topical Drug Market size in 2032 will be US$ 7109 million.

Who are the main players in the Compounded Topical Drug Market report?

Ans: The main players in the Compounded Topical Drug Market are Fagron, Fresenius Kabi, PharMEDium Services, Institutional Pharmacy Solutions, Cantrell Drug Company, Lorraine’s Pharmacy, B. Braun Melsungen AG Company, Perrigo Company plc, Nephron Pharmaceuticals Corporation, PCCA (Professional Compounding Centers of America), Medisca, Central Admixture Pharmacy Services (CAPS), Avella Specialty Pharmacy, Triangle Compounding Pharmacy, CareFirst Specialty Pharmacy, Pharmaca Integrative Pharmacy, QuVa Pharma, Custom Scripts Pharmacy, Atlas Pharmaceuticals

What are the Application segmentation covered in the Compounded Topical Drug Market report?

Ans: The Applications covered in the Compounded Topical Drug Market report are Hospitals, Retail Pharmacy, Other

What are the Type segmentation covered in the Compounded Topical Drug Market report?

Ans: The Types covered in the Compounded Topical Drug Market report are Gels, Ointments, Cream, Lotions

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Compounded Topical Drug Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Gels
1.2.3 Ointments
1.2.4 Cream
1.2.5 Lotions
1.3 Market by Application
1.3.1 Global Compounded Topical Drug Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospitals
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Compounded Topical Drug Market Perspective (2021–2032)
2.2 Global Compounded Topical Drug Growth Trends by Region
2.2.1 Global Compounded Topical Drug Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Compounded Topical Drug Historic Market Size by Region (2021–2026)
2.2.3 Compounded Topical Drug Forecasted Market Size by Region (2027–2032)
2.3 Compounded Topical Drug Market Dynamics
2.3.1 Compounded Topical Drug Industry Trends
2.3.2 Compounded Topical Drug Market Drivers
2.3.3 Compounded Topical Drug Market Challenges
2.3.4 Compounded Topical Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Compounded Topical Drug Players by Revenue
3.1.1 Global Top Compounded Topical Drug Players by Revenue (2021–2026)
3.1.2 Global Compounded Topical Drug Revenue Market Share by Players (2021–2026)
3.2 Global Top Compounded Topical Drug Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Compounded Topical Drug Revenue
3.4 Global Compounded Topical Drug Market Concentration Ratio
3.4.1 Global Compounded Topical Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Compounded Topical Drug Revenue in 2025
3.5 Global Key Players of Compounded Topical Drug Head Offices and Areas Served
3.6 Global Key Players of Compounded Topical Drug, Products and Applications
3.7 Global Key Players of Compounded Topical Drug, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Compounded Topical Drug Breakdown Data by Type
4.1 Global Compounded Topical Drug Historic Market Size by Type (2021–2026)
4.2 Global Compounded Topical Drug Forecasted Market Size by Type (2027–2032)
5 Compounded Topical Drug Breakdown Data by Application
5.1 Global Compounded Topical Drug Historic Market Size by Application (2021–2026)
5.2 Global Compounded Topical Drug Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Compounded Topical Drug Market Size (2021–2032)
6.2 North America Compounded Topical Drug Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Compounded Topical Drug Market Size by Country (2021–2026)
6.4 North America Compounded Topical Drug Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Compounded Topical Drug Market Size (2021–2032)
7.2 Europe Compounded Topical Drug Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Compounded Topical Drug Market Size by Country (2021–2026)
7.4 Europe Compounded Topical Drug Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Compounded Topical Drug Market Size (2021–2032)
8.2 Asia-Pacific Compounded Topical Drug Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Compounded Topical Drug Market Size by Region (2021–2026)
8.4 Asia-Pacific Compounded Topical Drug Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Compounded Topical Drug Market Size (2021–2032)
9.2 Latin America Compounded Topical Drug Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Compounded Topical Drug Market Size by Country (2021–2026)
9.4 Latin America Compounded Topical Drug Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Compounded Topical Drug Market Size (2021–2032)
10.2 Middle East & Africa Compounded Topical Drug Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Compounded Topical Drug Market Size by Country (2021–2026)
10.4 Middle East & Africa Compounded Topical Drug Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Fagron
11.1.1 Fagron Company Details
11.1.2 Fagron Business Overview
11.1.3 Fagron Compounded Topical Drug Introduction
11.1.4 Fagron Revenue in Compounded Topical Drug Business (2021–2026)
11.1.5 Fagron Recent Development
11.2 Fresenius Kabi
11.2.1 Fresenius Kabi Company Details
11.2.2 Fresenius Kabi Business Overview
11.2.3 Fresenius Kabi Compounded Topical Drug Introduction
11.2.4 Fresenius Kabi Revenue in Compounded Topical Drug Business (2021–2026)
11.2.5 Fresenius Kabi Recent Development
11.3 PharMEDium Services
11.3.1 PharMEDium Services Company Details
11.3.2 PharMEDium Services Business Overview
11.3.3 PharMEDium Services Compounded Topical Drug Introduction
11.3.4 PharMEDium Services Revenue in Compounded Topical Drug Business (2021–2026)
11.3.5 PharMEDium Services Recent Development
11.4 Institutional Pharmacy Solutions
11.4.1 Institutional Pharmacy Solutions Company Details
11.4.2 Institutional Pharmacy Solutions Business Overview
11.4.3 Institutional Pharmacy Solutions Compounded Topical Drug Introduction
11.4.4 Institutional Pharmacy Solutions Revenue in Compounded Topical Drug Business (2021–2026)
11.4.5 Institutional Pharmacy Solutions Recent Development
11.5 Cantrell Drug Company
11.5.1 Cantrell Drug Company Company Details
11.5.2 Cantrell Drug Company Business Overview
11.5.3 Cantrell Drug Company Compounded Topical Drug Introduction
11.5.4 Cantrell Drug Company Revenue in Compounded Topical Drug Business (2021–2026)
11.5.5 Cantrell Drug Company Recent Development
11.6 Lorraine’s Pharmacy
11.6.1 Lorraine’s Pharmacy Company Details
11.6.2 Lorraine’s Pharmacy Business Overview
11.6.3 Lorraine’s Pharmacy Compounded Topical Drug Introduction
11.6.4 Lorraine’s Pharmacy Revenue in Compounded Topical Drug Business (2021–2026)
11.6.5 Lorraine’s Pharmacy Recent Development
11.7 B. Braun Melsungen AG Company
11.7.1 B. Braun Melsungen AG Company Company Details
11.7.2 B. Braun Melsungen AG Company Business Overview
11.7.3 B. Braun Melsungen AG Company Compounded Topical Drug Introduction
11.7.4 B. Braun Melsungen AG Company Revenue in Compounded Topical Drug Business (2021–2026)
11.7.5 B. Braun Melsungen AG Company Recent Development
11.8 Perrigo Company plc
11.8.1 Perrigo Company plc Company Details
11.8.2 Perrigo Company plc Business Overview
11.8.3 Perrigo Company plc Compounded Topical Drug Introduction
11.8.4 Perrigo Company plc Revenue in Compounded Topical Drug Business (2021–2026)
11.8.5 Perrigo Company plc Recent Development
11.9 Nephron Pharmaceuticals Corporation
11.9.1 Nephron Pharmaceuticals Corporation Company Details
11.9.2 Nephron Pharmaceuticals Corporation Business Overview
11.9.3 Nephron Pharmaceuticals Corporation Compounded Topical Drug Introduction
11.9.4 Nephron Pharmaceuticals Corporation Revenue in Compounded Topical Drug Business (2021–2026)
11.9.5 Nephron Pharmaceuticals Corporation Recent Development
11.10 PCCA (Professional Compounding Centers of America)
11.10.1 PCCA (Professional Compounding Centers of America) Company Details
11.10.2 PCCA (Professional Compounding Centers of America) Business Overview
11.10.3 PCCA (Professional Compounding Centers of America) Compounded Topical Drug Introduction
11.10.4 PCCA (Professional Compounding Centers of America) Revenue in Compounded Topical Drug Business (2021–2026)
11.10.5 PCCA (Professional Compounding Centers of America) Recent Development
11.11 Medisca
11.11.1 Medisca Company Details
11.11.2 Medisca Business Overview
11.11.3 Medisca Compounded Topical Drug Introduction
11.11.4 Medisca Revenue in Compounded Topical Drug Business (2021–2026)
11.11.5 Medisca Recent Development
11.12 Central Admixture Pharmacy Services (CAPS)
11.12.1 Central Admixture Pharmacy Services (CAPS) Company Details
11.12.2 Central Admixture Pharmacy Services (CAPS) Business Overview
11.12.3 Central Admixture Pharmacy Services (CAPS) Compounded Topical Drug Introduction
11.12.4 Central Admixture Pharmacy Services (CAPS) Revenue in Compounded Topical Drug Business (2021–2026)
11.12.5 Central Admixture Pharmacy Services (CAPS) Recent Development
11.13 Avella Specialty Pharmacy
11.13.1 Avella Specialty Pharmacy Company Details
11.13.2 Avella Specialty Pharmacy Business Overview
11.13.3 Avella Specialty Pharmacy Compounded Topical Drug Introduction
11.13.4 Avella Specialty Pharmacy Revenue in Compounded Topical Drug Business (2021–2026)
11.13.5 Avella Specialty Pharmacy Recent Development
11.14 Triangle Compounding Pharmacy
11.14.1 Triangle Compounding Pharmacy Company Details
11.14.2 Triangle Compounding Pharmacy Business Overview
11.14.3 Triangle Compounding Pharmacy Compounded Topical Drug Introduction
11.14.4 Triangle Compounding Pharmacy Revenue in Compounded Topical Drug Business (2021–2026)
11.14.5 Triangle Compounding Pharmacy Recent Development
11.15 CareFirst Specialty Pharmacy
11.15.1 CareFirst Specialty Pharmacy Company Details
11.15.2 CareFirst Specialty Pharmacy Business Overview
11.15.3 CareFirst Specialty Pharmacy Compounded Topical Drug Introduction
11.15.4 CareFirst Specialty Pharmacy Revenue in Compounded Topical Drug Business (2021–2026)
11.15.5 CareFirst Specialty Pharmacy Recent Development
11.16 Pharmaca Integrative Pharmacy
11.16.1 Pharmaca Integrative Pharmacy Company Details
11.16.2 Pharmaca Integrative Pharmacy Business Overview
11.16.3 Pharmaca Integrative Pharmacy Compounded Topical Drug Introduction
11.16.4 Pharmaca Integrative Pharmacy Revenue in Compounded Topical Drug Business (2021–2026)
11.16.5 Pharmaca Integrative Pharmacy Recent Development
11.17 QuVa Pharma
11.17.1 QuVa Pharma Company Details
11.17.2 QuVa Pharma Business Overview
11.17.3 QuVa Pharma Compounded Topical Drug Introduction
11.17.4 QuVa Pharma Revenue in Compounded Topical Drug Business (2021–2026)
11.17.5 QuVa Pharma Recent Development
11.18 Custom Scripts Pharmacy
11.18.1 Custom Scripts Pharmacy Company Details
11.18.2 Custom Scripts Pharmacy Business Overview
11.18.3 Custom Scripts Pharmacy Compounded Topical Drug Introduction
11.18.4 Custom Scripts Pharmacy Revenue in Compounded Topical Drug Business (2021–2026)
11.18.5 Custom Scripts Pharmacy Recent Development
11.19 Atlas Pharmaceuticals
11.19.1 Atlas Pharmaceuticals Company Details
11.19.2 Atlas Pharmaceuticals Business Overview
11.19.3 Atlas Pharmaceuticals Compounded Topical Drug Introduction
11.19.4 Atlas Pharmaceuticals Revenue in Compounded Topical Drug Business (2021–2026)
11.19.5 Atlas Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Compounded Topical Drug Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Gels
 Table 3. Key Players of Ointments
 Table 4. Key Players of Cream
 Table 5. Key Players of Lotions
 Table 6. Global Compounded Topical Drug Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 7. Global Compounded Topical Drug Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 8. Global Compounded Topical Drug Market Size by Region (US$ Million), 2021–2026
 Table 9. Global Compounded Topical Drug Market Share by Region (2021–2026)
 Table 10. Global Compounded Topical Drug Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 11. Global Compounded Topical Drug Market Share by Region (2027–2032)
 Table 12. Compounded Topical Drug Market Trends
 Table 13. Compounded Topical Drug Market Drivers
 Table 14. Compounded Topical Drug Market Challenges
 Table 15. Compounded Topical Drug Market Restraints
 Table 16. Global Compounded Topical Drug Revenue by Players (US$ Million), 2021–2026
 Table 17. Global Compounded Topical Drug Market Share by Players (2021–2026)
 Table 18. Global Top Compounded Topical Drug Players by Tier (Tier 1, Tier 2, and Tier 3), based on Compounded Topical Drug Revenue, 2025
 Table 19. Ranking of Global Top Compounded Topical Drug Companies by Revenue (US$ Million) in 2025
 Table 20. Global 5 Largest Players Market Share by Compounded Topical Drug Revenue (CR5 and HHI), 2021–2026
 Table 21. Global Key Players of Compounded Topical Drug, Headquarters and Area Served
 Table 22. Global Key Players of Compounded Topical Drug, Products and Applications
 Table 23. Global Key Players of Compounded Topical Drug, Date of General Availability (GA)
 Table 24. Mergers and Acquisitions, Expansion Plans
 Table 25. Global Compounded Topical Drug Market Size by Type (US$ Million), 2021–2026
 Table 26. Global Compounded Topical Drug Revenue Market Share by Type (2021–2026)
 Table 27. Global Compounded Topical Drug Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 28. Global Compounded Topical Drug Revenue Market Share by Type (2027–2032)
 Table 29. Global Compounded Topical Drug Market Size by Application (US$ Million), 2021–2026
 Table 30. Global Compounded Topical Drug Revenue Market Share by Application (2021–2026)
 Table 31. Global Compounded Topical Drug Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 32. Global Compounded Topical Drug Revenue Market Share by Application (2027–2032)
 Table 33. North America Compounded Topical Drug Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 34. North America Compounded Topical Drug Market Size by Country (US$ Million), 2021–2026
 Table 35. North America Compounded Topical Drug Market Size by Country (US$ Million), 2027–2032
 Table 36. Europe Compounded Topical Drug Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 37. Europe Compounded Topical Drug Market Size by Country (US$ Million), 2021–2026
 Table 38. Europe Compounded Topical Drug Market Size by Country (US$ Million), 2027–2032
 Table 39. Asia-Pacific Compounded Topical Drug Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 40. Asia-Pacific Compounded Topical Drug Market Size by Region (US$ Million), 2021–2026
 Table 41. Asia-Pacific Compounded Topical Drug Market Size by Region (US$ Million), 2027–2032
 Table 42. Latin America Compounded Topical Drug Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 43. Latin America Compounded Topical Drug Market Size by Country (US$ Million), 2021–2026
 Table 44. Latin America Compounded Topical Drug Market Size by Country (US$ Million), 2027–2032
 Table 45. Middle East & Africa Compounded Topical Drug Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 46. Middle East & Africa Compounded Topical Drug Market Size by Country (US$ Million), 2021–2026
 Table 47. Middle East & Africa Compounded Topical Drug Market Size by Country (US$ Million), 2027–2032
 Table 48. Fagron Company Details
 Table 49. Fagron Business Overview
 Table 50. Fagron Compounded Topical Drug Product
 Table 51. Fagron Revenue in Compounded Topical Drug Business (US$ Million), 2021–2026
 Table 52. Fagron Recent Development
 Table 53. Fresenius Kabi Company Details
 Table 54. Fresenius Kabi Business Overview
 Table 55. Fresenius Kabi Compounded Topical Drug Product
 Table 56. Fresenius Kabi Revenue in Compounded Topical Drug Business (US$ Million), 2021–2026
 Table 57. Fresenius Kabi Recent Development
 Table 58. PharMEDium Services Company Details
 Table 59. PharMEDium Services Business Overview
 Table 60. PharMEDium Services Compounded Topical Drug Product
 Table 61. PharMEDium Services Revenue in Compounded Topical Drug Business (US$ Million), 2021–2026
 Table 62. PharMEDium Services Recent Development
 Table 63. Institutional Pharmacy Solutions Company Details
 Table 64. Institutional Pharmacy Solutions Business Overview
 Table 65. Institutional Pharmacy Solutions Compounded Topical Drug Product
 Table 66. Institutional Pharmacy Solutions Revenue in Compounded Topical Drug Business (US$ Million), 2021–2026
 Table 67. Institutional Pharmacy Solutions Recent Development
 Table 68. Cantrell Drug Company Company Details
 Table 69. Cantrell Drug Company Business Overview
 Table 70. Cantrell Drug Company Compounded Topical Drug Product
 Table 71. Cantrell Drug Company Revenue in Compounded Topical Drug Business (US$ Million), 2021–2026
 Table 72. Cantrell Drug Company Recent Development
 Table 73. Lorraine’s Pharmacy Company Details
 Table 74. Lorraine’s Pharmacy Business Overview
 Table 75. Lorraine’s Pharmacy Compounded Topical Drug Product
 Table 76. Lorraine’s Pharmacy Revenue in Compounded Topical Drug Business (US$ Million), 2021–2026
 Table 77. Lorraine’s Pharmacy Recent Development
 Table 78. B. Braun Melsungen AG Company Company Details
 Table 79. B. Braun Melsungen AG Company Business Overview
 Table 80. B. Braun Melsungen AG Company Compounded Topical Drug Product
 Table 81. B. Braun Melsungen AG Company Revenue in Compounded Topical Drug Business (US$ Million), 2021–2026
 Table 82. B. Braun Melsungen AG Company Recent Development
 Table 83. Perrigo Company plc Company Details
 Table 84. Perrigo Company plc Business Overview
 Table 85. Perrigo Company plc Compounded Topical Drug Product
 Table 86. Perrigo Company plc Revenue in Compounded Topical Drug Business (US$ Million), 2021–2026
 Table 87. Perrigo Company plc Recent Development
 Table 88. Nephron Pharmaceuticals Corporation Company Details
 Table 89. Nephron Pharmaceuticals Corporation Business Overview
 Table 90. Nephron Pharmaceuticals Corporation Compounded Topical Drug Product
 Table 91. Nephron Pharmaceuticals Corporation Revenue in Compounded Topical Drug Business (US$ Million), 2021–2026
 Table 92. Nephron Pharmaceuticals Corporation Recent Development
 Table 93. PCCA (Professional Compounding Centers of America) Company Details
 Table 94. PCCA (Professional Compounding Centers of America) Business Overview
 Table 95. PCCA (Professional Compounding Centers of America) Compounded Topical Drug Product
 Table 96. PCCA (Professional Compounding Centers of America) Revenue in Compounded Topical Drug Business (US$ Million), 2021–2026
 Table 97. PCCA (Professional Compounding Centers of America) Recent Development
 Table 98. Medisca Company Details
 Table 99. Medisca Business Overview
 Table 100. Medisca Compounded Topical Drug Product
 Table 101. Medisca Revenue in Compounded Topical Drug Business (US$ Million), 2021–2026
 Table 102. Medisca Recent Development
 Table 103. Central Admixture Pharmacy Services (CAPS) Company Details
 Table 104. Central Admixture Pharmacy Services (CAPS) Business Overview
 Table 105. Central Admixture Pharmacy Services (CAPS) Compounded Topical Drug Product
 Table 106. Central Admixture Pharmacy Services (CAPS) Revenue in Compounded Topical Drug Business (US$ Million), 2021–2026
 Table 107. Central Admixture Pharmacy Services (CAPS) Recent Development
 Table 108. Avella Specialty Pharmacy Company Details
 Table 109. Avella Specialty Pharmacy Business Overview
 Table 110. Avella Specialty Pharmacy Compounded Topical Drug Product
 Table 111. Avella Specialty Pharmacy Revenue in Compounded Topical Drug Business (US$ Million), 2021–2026
 Table 112. Avella Specialty Pharmacy Recent Development
 Table 113. Triangle Compounding Pharmacy Company Details
 Table 114. Triangle Compounding Pharmacy Business Overview
 Table 115. Triangle Compounding Pharmacy Compounded Topical Drug Product
 Table 116. Triangle Compounding Pharmacy Revenue in Compounded Topical Drug Business (US$ Million), 2021–2026
 Table 117. Triangle Compounding Pharmacy Recent Development
 Table 118. CareFirst Specialty Pharmacy Company Details
 Table 119. CareFirst Specialty Pharmacy Business Overview
 Table 120. CareFirst Specialty Pharmacy Compounded Topical Drug Product
 Table 121. CareFirst Specialty Pharmacy Revenue in Compounded Topical Drug Business (US$ Million), 2021–2026
 Table 122. CareFirst Specialty Pharmacy Recent Development
 Table 123. Pharmaca Integrative Pharmacy Company Details
 Table 124. Pharmaca Integrative Pharmacy Business Overview
 Table 125. Pharmaca Integrative Pharmacy Compounded Topical Drug Product
 Table 126. Pharmaca Integrative Pharmacy Revenue in Compounded Topical Drug Business (US$ Million), 2021–2026
 Table 127. Pharmaca Integrative Pharmacy Recent Development
 Table 128. QuVa Pharma Company Details
 Table 129. QuVa Pharma Business Overview
 Table 130. QuVa Pharma Compounded Topical Drug Product
 Table 131. QuVa Pharma Revenue in Compounded Topical Drug Business (US$ Million), 2021–2026
 Table 132. QuVa Pharma Recent Development
 Table 133. Custom Scripts Pharmacy Company Details
 Table 134. Custom Scripts Pharmacy Business Overview
 Table 135. Custom Scripts Pharmacy Compounded Topical Drug Product
 Table 136. Custom Scripts Pharmacy Revenue in Compounded Topical Drug Business (US$ Million), 2021–2026
 Table 137. Custom Scripts Pharmacy Recent Development
 Table 138. Atlas Pharmaceuticals Company Details
 Table 139. Atlas Pharmaceuticals Business Overview
 Table 140. Atlas Pharmaceuticals Compounded Topical Drug Product
 Table 141. Atlas Pharmaceuticals Revenue in Compounded Topical Drug Business (US$ Million), 2021–2026
 Table 142. Atlas Pharmaceuticals Recent Development
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Compounded Topical Drug Picture
 Figure 2. Global Compounded Topical Drug Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Compounded Topical Drug Market Share by Type: 2025 vs 2032
 Figure 4. Gels Features
 Figure 5. Ointments Features
 Figure 6. Cream Features
 Figure 7. Lotions Features
 Figure 8. Global Compounded Topical Drug Market Size by Application (US$ Million), 2021–2032
 Figure 9. Global Compounded Topical Drug Market Share by Application: 2025 vs 2032
 Figure 10. Hospitals Case Studies
 Figure 11. Retail Pharmacy Case Studies
 Figure 12. Other Case Studies
 Figure 13. Compounded Topical Drug Report Years Considered
 Figure 14. Global Compounded Topical Drug Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 15. Global Compounded Topical Drug Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 16. Global Compounded Topical Drug Market Share by Region: 2025 vs 2032
 Figure 17. Global Compounded Topical Drug Market Share by Players in 2025
 Figure 18. Global Compounded Topical Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 19. The Top 10 and 5 Players Market Share by Compounded Topical Drug Revenue in 2025
 Figure 20. North America Compounded Topical Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 21. North America Compounded Topical Drug Market Share by Country (2021–2032)
 Figure 22. United States Compounded Topical Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Canada Compounded Topical Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. Europe Compounded Topical Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. Europe Compounded Topical Drug Market Share by Country (2021–2032)
 Figure 26. Germany Compounded Topical Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. France Compounded Topical Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. U.K. Compounded Topical Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Italy Compounded Topical Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Russia Compounded Topical Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Ireland Compounded Topical Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Asia-Pacific Compounded Topical Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Asia-Pacific Compounded Topical Drug Market Share by Region (2021–2032)
 Figure 34. China Compounded Topical Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Japan Compounded Topical Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. South Korea Compounded Topical Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Southeast Asia Compounded Topical Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. India Compounded Topical Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Australia & New Zealand Compounded Topical Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Latin America Compounded Topical Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Latin America Compounded Topical Drug Market Share by Country (2021–2032)
 Figure 42. Mexico Compounded Topical Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Brazil Compounded Topical Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Middle East & Africa Compounded Topical Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Middle East & Africa Compounded Topical Drug Market Share by Country (2021–2032)
 Figure 46. Israel Compounded Topical Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Saudi Arabia Compounded Topical Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. UAE Compounded Topical Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 49. Fagron Revenue Growth Rate in Compounded Topical Drug Business (2021–2026)
 Figure 50. Fresenius Kabi Revenue Growth Rate in Compounded Topical Drug Business (2021–2026)
 Figure 51. PharMEDium Services Revenue Growth Rate in Compounded Topical Drug Business (2021–2026)
 Figure 52. Institutional Pharmacy Solutions Revenue Growth Rate in Compounded Topical Drug Business (2021–2026)
 Figure 53. Cantrell Drug Company Revenue Growth Rate in Compounded Topical Drug Business (2021–2026)
 Figure 54. Lorraine’s Pharmacy Revenue Growth Rate in Compounded Topical Drug Business (2021–2026)
 Figure 55. B. Braun Melsungen AG Company Revenue Growth Rate in Compounded Topical Drug Business (2021–2026)
 Figure 56. Perrigo Company plc Revenue Growth Rate in Compounded Topical Drug Business (2021–2026)
 Figure 57. Nephron Pharmaceuticals Corporation Revenue Growth Rate in Compounded Topical Drug Business (2021–2026)
 Figure 58. PCCA (Professional Compounding Centers of America) Revenue Growth Rate in Compounded Topical Drug Business (2021–2026)
 Figure 59. Medisca Revenue Growth Rate in Compounded Topical Drug Business (2021–2026)
 Figure 60. Central Admixture Pharmacy Services (CAPS) Revenue Growth Rate in Compounded Topical Drug Business (2021–2026)
 Figure 61. Avella Specialty Pharmacy Revenue Growth Rate in Compounded Topical Drug Business (2021–2026)
 Figure 62. Triangle Compounding Pharmacy Revenue Growth Rate in Compounded Topical Drug Business (2021–2026)
 Figure 63. CareFirst Specialty Pharmacy Revenue Growth Rate in Compounded Topical Drug Business (2021–2026)
 Figure 64. Pharmaca Integrative Pharmacy Revenue Growth Rate in Compounded Topical Drug Business (2021–2026)
 Figure 65. QuVa Pharma Revenue Growth Rate in Compounded Topical Drug Business (2021–2026)
 Figure 66. Custom Scripts Pharmacy Revenue Growth Rate in Compounded Topical Drug Business (2021–2026)
 Figure 67. Atlas Pharmaceuticals Revenue Growth Rate in Compounded Topical Drug Business (2021–2026)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools